Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 22, 2014
MALDI imaging of predictive ferritin, fibrinogen and proteases in haemophilic arthropathyM Kriegsmann, R Casadonte, T Randau, et al.Der Orthopade|May 21, 2009
[Applications of molecular pathology in the diagnosis of joint infections]J Kriegsmann, T Hopf, D Jacobs, et al.Scandinavian Journal of Rheumatology|May 30, 2012
MALDI MS imaging as a powerful tool for investigating synovial tissueM Kriegsmann, E H Seeley, A Schwarting, et al.Pulmonology|April 13, 2024
Low tumor interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation studyS Safi, J Krzykalla, H Hoffmann, et al.Cardiovascular and Interventional Radiology|June 3, 2018
Inherently Radiopaque Narrow-Size-Calibrated Microspheres: Proof of Principle in a Pig Embolization ModelChristof M Sommer, A Harms, T D Do, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2024
Aliado - A design concept of AI for decision support in oncological liver surgeryA Schulze, M Haselbeck-Köbler, J M Brandenburg, et al.ESMO Open|September 6, 2021
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinomaM Kirchner, K Kluck, R Brandt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinomaS M Dieter, C Heining, A Agaimy, et al.Lung Cancer (Amsterdam, Netherlands)|September 2, 2020
Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencingP Christopoulos, M Kirchner, J Roeper, et al.ESMO Open|September 4, 2021
Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerG Mountzios, E Samantas, K Senghas, et al.Pageof 3